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Abstract
Background: Nonsteroidal anti-inflammatory drugs (NSAID) represent a one of the most widely used anti-
inflammatory substances. Their anti-inflammatory effects are mainly based on inhibition of cyclooxygenase. The
potential direct effect of NSAID on leukocyte migration was poorly investigated. Using time-lapse microscopy and
96-well fluorescence-based assay, we studied the effect of three different NSAID, ketoprofen, diclofenac and SC-560,
on leukocyte haptokinesis and haptotaxis in vivo and in vitro.
Results: NSAID induced an immediate inhibiting effect on leukocyte migration both in vitro and in vivo. This effect
was dose-dependent and was not restricted to a specific type of leukocytes. The inhibition of leukocyte migration
by NSAID was partially re-stored after removal of inhibiting agent. Only complete blockade of leukocyte migration
was accompanied by a strong reduction of [Ca
2+]i.
Conclusions: NSAID strongly supress leukocyte migration. The results of the present study may have important
clinical implications since blockade of leukocyte migration can be achieved after topical application of NSAID.
Background
Migration is an important feature of leukocytes which
represents a pre-requisite for normal leukocyte function
in physiological processes such as protection against
infection or foreign antigens. Under pathological condi-
tions, leukocytes infiltrate tissue which locally produces
pro-inflammatory substances and chemokines. This pro-
cess is known as leukocyte recruitment. The normal
ability for active movement is an important pre-requisite
for the effective recruitment of leukocytes from the
microvascular circulation [1]. The blockade of leukocyte
migration can abrogate the process of leukocyte recruit-
ment and inflammation. Therefore, the modulation of
leukocyte migration has been proposed as a potential
therapeutic approach for the treatment of several
inflammatory diseases such as psoriasis, eczema, multi-
ple sclerosis and arthritis [2,3].
Dependent on the tissue structure, two types of non-
directed leukocyte migration can be identified: two- and
three-dimensional haptokinesis. Two-dimensional
leukocyte haptokinesis can be found on two-dimensional
surfaces, such as inner vessel walls, the peritoneum and
the pleura. Three-dimensional haptokinetic migration
occurs in the tissue which contains cellular or fibrillar
extracellular matrix components promoting leukocyte
movement [1]. Prevailing random haptokinetic leukocyte
migration becomes directional (hapto- or chemotactic),
if a gradient of chemotacic agent is present in the tissue.
Chemotaxis is induced by soluble, freely diffusing com-
pounds that lead to preferential signaling and actin-rich
protrusions at the leading edge. In contrast to chemo-
taxis, haptotaxis represents the directed migration
toward chemoattractants which are immobilized on tis-
sue structures, such as interstitial collagens or stromal
cell network [1].
Nonsteroidal anti-inflammatory drugs (NSAID) are
one of the most widely used anti-inflammatory sub-
stances. The major anti-inflammatory effect of NSAID is
the inhibition of cyclooxygenase (COX) enzyme system
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quence, to reduction of inflammation, pain and fever [4].
It has also been shown that COX inhibition by NSAID
reduces migratory activity of leukocytes which therefore
leads to a reduction of leukocyte recruitment into the
inflamed tissue. Although the effect of some NSAID
such as aspirin, indometacin or ketoprofen on leukocyte
migration was investigated in several previous studies
[5,6], these studies were mainly focused on the changes
of migration of polymorphonucelar leukocytes (PMNs)
and did not analyze effects of NSAID at the single leu-
kocyte level. In the present study, we studied the effect
of three different NSAID, ketoprofen, diclofenac and
SC-560 on the haptokinesis and haptotaxis of PMNs
and activated lymphocytes at the single cell level in vitro
and in vivo using time-lapse microscopy. The study was
in particular aimed to identify the effective concentra-
tions of NSAID which can suppress leukocyte migration.
Furthermore, the toxic potential of these NSAID and
t h er o l eo fC a
2+ were analyzed. Ketoprofen and diclofe-
nac are known to inhibit both COX-1 and COX-2
whereas SC-560 belongs to the group of COX-1-selec-
tive inhibitors.
Methods
Leukocytes preparation
Polymorphonuclear leukocytes (PMNs) or lymphocytes
were isolated from human venous peripheral blood
using density gradient centrifugation (Biocoll, Biochrom
AG, Berlin, Germany). Microscopic examination showed
that at least 90% of isolated polymorphonuclear leuko-
cytes were represented by neutrophils. For the 3D hap-
totaxis, isolated human PMNs or lymphocytes were
used immediately after isolation. In some experiments,
lymphocytes were activated for 5 days at 37°C using 1.5
μg/ml of concanavalin A (Calbiochem, Darmstadt,
Germany) in Iscove’s Modified DMEM supplemented
with 10% FCS (c.c.pro, Oberdorla, Germany). To study
inhibitory effects on leukocyte migration, the following
NSAID were used: ketoprofen (ct-Arzneimittel GmbH,
Berlin, Germany), diclofenac (Novartis Pharma GmbH,
Nürnberg, Germany), SC-560 (Cayman Chemical, Ann
Arbor, Michigan, USA).
Analysis of leukocyte haptokinesis
Leukocyte migration in collagen matrix in vitro was
analyzed using modified 96-wells collagen matrix assay
as previously described [7]. For this assay, 100 μl/well of
collagen mixture was prepared and polymerized for 30
min at 37°C. 100 μl of leukocyte suspension (10.000
cells/well) containing different concentrations of NSAID
was layered upon the collagen gel. Plates were incubated
at 37°C for 60 Min to allow migrating leukocytes
to invade into collagen gel. The suspension of
non-invading leukocytes were washed using Multi-
Reagent Washer (Dynatech, Gaithersberg, USA). 5 μM/
well of Calcein AM (MoBiTec, Goetingen, Germany)
were added and incubated for 30 min. The fluorescence
was measured using multilable counter (Victor 1420,
Perkin&Elmer Wallac GmbH, Freiburg, Germany). The
number of invaded leukocytes was calculated using
reference concentration of leukocytes and was expressed
as a percentage of migrating leukocytes to total leuko-
cyte number.
For time-lapse microscopy, 4 × 10
5 cells in 50 μlo f
PBS were added to the collagen mixture in a petri plate
prior the polymerization. Digital time-lapse microscopy
was performed after application of different concentra-
tions of ketoprofen to the gel as previously described
[7]. Leukocyte movement was recorded for 20 min. Sub-
sequently, gel preparation was washed with PBS and
recorded for further 30 min. Six experiments for each
group were performed.
Analysis of leukocyte haptotaxis
Leukocytes invasion into the collagen matrix was
analyzed. For this aim, 5 μl of collagen matrix mixture
were prepared on ice as previously described [7].
Additionally, this mixture contained IL-8 (10 ng/ml) or
SDF-1 (100 ng/ml; R&D Systems, Wiesbaden, Germany)
and ketoprofen and filled into the glass square tube (1 ×
1 mm, Vitrocom, Mountain Lakes, NJ, USA). Collagen
matrix was allowed to polymerize for 30 min at 37°C. 5
μl of leukocyte suspension (2.000 cells/μl) was added
upon collagen matrix. The tube was fixed in the upright
position and incubated at 37°C for 3 hours for neutro-
phils or 24 hours for lymphocytes. The distance of
leukocyte invasion into the matrix was recorded using
microscope and measured using Histo software
(W. Gross, University of Heidelberg, Germany).
Intravital microscopy
Five male lysEGFP-ki mice (10-12 weeks) were used.
These mice allow an excellent visualization of EGFP-
expressing neutrophils using fluorescence microscopy.
To induce local leukocyte activation and extravasation,
20 μl of IL-8 (R&D Systems) was injected onto the auri-
cle. An excessive amount of ketoprofen gel (2.5% keto-
profen; Effekton, Teofarma, Pavia, Italy) was applied on
the skin of the auricle before or 60 min after IL-8 injec-
tion. Blood vessels were visualized using intravenous
injection of 0.6 mg of TRITC-labelled albumin (Sigma
Aldrich, Deisenhofen, Germany). Time-lapse intravital
microscopy of auricle was performed using fluorescence
microscope (Axio Observer, Zeiss GmbH, Jena, Ger-
many) combined with image deconvolution (Huygens
Essential, SVI, Hilversum, Netherlands). The speed and
the fraction of migrating leukocytes were measured
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Heidelberg, Germany). All experiments were approved
by the local committee of animal care (Regierungspräsi-
dium Karlsruhe).
Toxicity assays
Potential cytotoxic effect of NSAID on PMNs was mea-
sured using Calcein AM assay (MoBiTec) as described
in manufacturer’s instruction. In brief, leukocytes were
incubated with different concentrations of NSAID for
60 min at 37°C and loaded with 5 μM Calcein AM.
Vital cells metabolised calcein and produced fluorescent
signal which was measured using fluorimeter (Victor
1420) and expressed as a percent of the non-treated
control. Three experiments for every substance were
performed.
[Ca
2+]i measurement
Ca
2+ was measured as previously described by Nobiling
and Bührle [8]. In brief, isolated leukocytes were incu-
bated in collagen gel for 30 min and were loaded with 2
μM of FURA-2 AM (Molecular Probes, Eugene, USA).
Intracellular Ca
2+ ([Ca
2+]i) signal was recorded at alter-
nately 340 and 360 nm wavelength for 15 sec at three
stages: at baseline, after application of 2 and 4 mM
ketoprofen and after removal of ketoprofen by washing.
[Ca
2+]i concentration was calculated as 340/360 nm
ratio and expressed in μM.
Statistical analysis
Statistical analysis was performed using SPSS software
(Version 11.5.1, SPSS Inc., Chicago, USA). All data are
given as mean ± SD. To study differences between the
groups, Wilcoxon or Mann-Whitney-U-test were used,
if appropriate. p < 0.05 was considered as significant.
Results
NSAID inhibit leukocyte migration in vitro
The influence of different concentrations of NSAID on
leukocyte haptokinesis in collagen matrix was studied
using a 96-well Calcein assay. Neutrophils or activated
lymphocytes showed an active migration in the collagen
matrix. There were no inhibiting effects on leukocyte
migration of low concentrations of NSAID. We found
that all used NSAID (ketoprofen, diclofenac, SC-560)
inhibited migration of both neutrophils and lymphocytes
in a dose-dependent manner in vitro (Figure 1A-C).
Depending on the selecting drug and on the leukocyte
population (PMNs or lymphocytes), the dose of 0.6-4.0
mM led to complete blockade of leukocyte migration
(Figure 1). Ketoprofen showed the highest IC50 on leu-
kocyte migration whereas diclofenac had the lowest
IC50 (Table 1).
Toxicity assay showed that only highest concentra-
tions of ketoprofen (4 mM) and diclofenac (2.5-5
mM) led to significant reduction of the cell number.
5 mM diclofenac destroyed almost all leukocytes after
6 0m i ni n c u b a t i o n( F i g u r e1 D - E ) .N or e d u c t i o no f
leukocyte number was found after incubation with
SC-560.
Inhibition of leukocyte migration by NSAID is reversible
Since all NSAID showed a similar inhibiting effect on
leukocyte migration, further experiments using
time-lapse microscopy were focused on the effects of
ketoprofen. We found that the percent of migrating leu-
kocytes in collagen gel was 87 ± 6%, whereas the mean
speed of leukocyte migration was 3.2 ± 1.3 μm/min.
Migrating leukocytes showed a multipolar polarized
shape and stable random movement (haptokinesis) over
a long time period.
Leukocyte migration in control group was stable
(Figure 2). The concentration of 0.08 mM ketoprofen
significantly decreased speed, whereas a concentration
of 4 mM caused a total blockade of leukocyte migration
(Figure 2). These effects were found immediately after
application of NSAID. Washing-out of ketoprofen led to
a recovery of leukocyte migration, although the speed of
movement after recovery didn o ta c h i e v ei t sb a s e l i n e
value (Figure 2C-D).
NSAID blocked leukocytes invasion in vitro and
prevented leukocyte recruitment in vivo
To study leukocyte haptotaxis, we analyzed leukocyte
invasion into the collagen matrix with or without che-
mokine. In this assay, leukocytes showed a superficial
invasion into the collagen matrix, if no chemoattractants
were added to the collagen. IL-8 or SDF-1 induced a
strong directed invasion of both neutrophils and
lymphocytes into the collagen matrix (Figure 3A-B).
Interestingly, addition of 0.4 and 2 mM ketoprofen to
the matrix inhibited leukocyte penetration in a dose-
dependent manner whereas 4 mM ketoprofen prevented
leukocyte invasion into the matrix (Figure 3A-B).
Intravital microscopy showed that the cutaneous injec-
tion of IL-8 induced a strong intravascular activation
and extravasation of leukocytes, which infiltrated
cutaneous tissue within several minutes (Figure 3C-D,
Table 1 Mean IC50 (μM) for inhibition of leukocyte
migration by NSAID.
substance PMNs lymphocytes
ketoprofen 760 1050
diclofenac 110 70
SC-560 200 220
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Figure 1 A-C: Effect of NSAID on leukocyte migration: changes of migratory activity of isolated human lymphocytes and granulocytes
were measured using 96-wells calcein AM assay. Ketoprofen (A), diclofenac (B) or SC-560 (C) showed a dose-dependent inhibition of PMNs
and lymphocyte migration. D-F: Toxic effect of NSAID on PMNs: Leukocytes were incubated for 60 min with different concentrations of
ketoprofen (D), diclofenac (E) and SC-560 (F). Cell number was measured using Calcein AM uptake. Only highest concentrations of ketoprofen
(4 mM) and diclofenac (2.5-5 mM) induced significant reduction of the leukocyte number.
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Figure 2 Effect of ketoprofen on single leukocyte migration: A-B: Leukocyte migration was studied using digital time-lapse
microscopy. Ketoprofen caused a dose-dependent inhibition of leukocyte speed (A) which partially recovered after the removal of ketoprofen
(B). C: Representative images of migrating leukocytes in collagen matrix at baseline, leukocyte depolarization 5 min after application of 2 mM of
ketoprofen and partial restitution of leukocyte migration after removal of ketoprofen. D-E: Blockade of activated leukocytes using topic
application of ketoprofen in vivo: quantitative analysis of leukocyte speed (D) and representative image of intravital microscopy (E). Application
of ketoprofen gel 60 min after IL-8 injection caused a rapid leukocyte depolarization and movement stop (leukocytes are showed as green-
fluorescent cells).
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Figure 3 Leukocyte repulsion by ketoprofen: Representative images (A) and quantitative analysis (B) of leukocyte penetration of
collagen matrix in vitro. C: Prevention of leukocyte infiltration after topic application of ketoprofen in vivo prior the IL-8 injection. D:
Representative image of intravital microscopy. Leukocytes appeared in green, blood vessels were visualized using i.v. injection of TRITC-
conjugated albumin (orange). IL-8 strongly activated leukocyte extravasation and migration, whereas almost no leukocytes were found if
ketoprofen gel was locally applied on skin prior the IL-8 injection.
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cation of ketoprofen gel to the auricle led to the lost of
leukocyte polarization and the blockade of leukocyte
migration (Figure 2D-E), which was observed within
several minutes after ketoprofen application. If ketopro-
fen gel was applied before IL-8 injection, leukocyte
recruitment and infiltration were almost absent
(Figure 3C-D, Additional file 2, Movie 2).
Ketoprofen decreases intracellular [Ca
2+]i in migrating
human granulocytes in vitro
Leukocytes of control experiments showed a well-
polarised shape and a constant [Ca
2+]i signal. Ketoprofen
concentration of 2-4 mM caused a rapid leukocyte depo-
larisation (Figure 2C). No significant changes of [Ca
2+]i
were found after addition of 2 mM ketoprofen (Figure 4).
Interestingly, the increase of ketoprofen concentration to
4 mM led to a dramatic decrease of [Ca
2+]i signal. The
higher the initial value of [Ca
2+]i, the sharper was its
decline (Figure 4). The washing-out of ketoprofen led to a
partial restoration of [Ca
2+]i signal (Figure 4).
Discussion
In the present study, the effect of three different NSAID,
ketoprofen, diclofenac, SC-560 on leukocyte haptotaxis
and haptokinesis was analyzed. We found that all used
NSAID inhibited leukocyte migration of in a dose-
dependent manner both in vivo and in vitro. At the sin-
gle cell level, NSAID inhibited both leukocyte speed and
the fraction of migrating leukocytes. This effect occurred
immediately after NSAID application and was partially
restored after removal of inhibiting agent. Interestingly,
inhibiting effect of NSAID was not dependent on the
type of leukocytes, since migration of both PMNs and
lymphocytes was inhibited by equivalent concentrations.
The inhibitory effect of ketoprofen was reproducible in
Calcein-based assay and in time-lapse microscopy. Inter-
estingly, inhibiting effect of NSAID on leukocyte migra-
tion is reversible. As shown in the present study,
leukocytes re-store their migration if NSAID concentra-
tion decreases. Results of the present study correspond
well with previous results which analyzed the effect of
some NSAID such as aspirin, indomethacin or ketopro-
fen on leukocyte migration [5,6]. These studies showed
that NSAID inhibit chemotaxis of polymorphonuclear
leukocytes (PMNs). In contrast to previous studies, we
analyzed both PMN and T cell migration, studied hapto-
tactic movement and showed changes of leukocyte
migration at the single cell level in vivo and in vitro.
We also showed that 4 mM ketoprofen stopped leuko-
cyte invasion into the IL-8 orS D F - 1 - c o n t a i n i n gm a t r i x
in vitro. This effect was also studied in vivo using time-
lapse intravital microscopy. IL-8 and SDF-1 are two
important chemokines which control leukocyte chemo-
and haptotaxis by binding to the CXCL8 and to
CXCL12 chemokine receptor, respectively [9,10]. Leuko-
cyte recruitment and infiltration were effectively pre-
vented if ketoprofen was locally applied in vivo prior the
pro-inflammatory stimulation. We believe that the repel-
lent action of NSAID is the direct consequence of their
blocking effect on leukocyte migration both in vivo and
in vitro. Ketoprofen blocked leukocyte migration for at
least one hours. The potential resuming of leukocyte
movement after the longer exposure to ketoprofen were
not analyzed.
Previous studies showed that NSAID inhibit COX at a
concentration of 10
-5-10
-3M. The inhibition of COX is a
major, but not a single mechanism of potential NSAID
effects. In the present study, the initial inhibition of leu-
kocyte migration was found at NSAID concentrations
beginning from 10-50 μMa n dt h eI C 5 0v a r i e df r o m7 0
to 1050 μM. This concentrations is 10-fold higher than
the highest known IC50 required for COX inhibition for
diclofenac and SC-560 whereas this difference for keto-
profen is 500-fold [11,12]. Therefore, we believe that the
Figure 4 Individual values of [Ca
2+]i changes (A) and the time-
course of a single representative measurement (B). [Ca
2+]i was
measured using cell labelling with Fura-2 and ultrasensitive single-
cell-based fluorimetry. 4 mM, but not 2 mM ketoprofen caused
rapid decrease of [Ca
2+]i, which was partially restored after removal
of ketoprofen.
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cannot only represent a COX-dependent phenomenon,
but other mechanisms may participate in the NSAID
action on leukocyte migration. The data of the present
study correspond well with results of previous studies.
These studies demonstrated that NSAID have an inhi-
biting effect on chemotaxis of PMNs at high concentra-
tions in vitro which was independent of their potency as
prostaglandin inhibitors [6,13]. In contrast to these stu-
dies, we showed that not only chemotactic, but also
haptokinetic migratory activity of single leukocytes can
be blocked by NSAID. Furthermore, almost all previous
studies focused on the changes of migration of polymor-
phonuclear leukocytes, whereas the effect of NSAID on
lymphocyte migration was poorly investigated. Results of
the present study demonstrated that NSAID have simi-
lar inhibiting effects on migration of both PMNs and
lymphocytes and that lymphocyte movement can be
stopped by NSAID.
Other previous studies showed that low concentra-
tions of NSAID inhibit COX production by activated
mast cells and macrophages and reduce inflammation-
induced leukocyte infiltration [14,15]. Although COX
inhibition by low concentrations of NSAID can reduce
leukocyte infiltration in inflamed tissue, this effect can
be produced by rather different mechanism than the
direct inhibition of leukocyte migration. We believe that
COX-related effects of NSAID are not a major factor
for the direct inhibition of leukocyte migration. Further-
more, we propose that other possible mechanisms of
NSAID action such as inhibition of intracellular ATP
[16,17], calcium metabolism [18] or [Ca
2+]i-dependent
myosin II activation [19,20] can be responsible for the
inhibition of leukocyte migration. The results of the pre-
s e n ts t u d yc o n f i r m e dt h ei m p o r t a n tr o l eo fC a
2+ signal-
i n gi nN S A I Da c t i o na n ds h o w e dt h a tt h es t o po f
leukocyte migration by ketoprofen was accompanied by
t h ed r a m a t i cd e c r e a s eo f[ C a
2+]i and by the cytotoxic
effect whereas partial inhibition of leukocyte migration
did not cause a significant reduction of [Ca
2+]i and did
not induce cell toxicity.
Concentrations of NSAID, which are required for
blockade of leukocyte migration, are high. As showed
in previous studies, high NSAID concentration cause
toxic side effects, if these substances are systemically
applied [21]. However, NSAID do not induce systemic
toxic side effects after topic application as gel or salve
formulation [22,23] or after intraarticular injection.
Previous studies showed that ketoprofen has a high
percutaneous penetration [24,25]. The present study
showed that the topic application of concentrated
ketoprofen gel (2.5% ketoprofen) rapidly blocked
migration of cutaneous leukocytes. We believe that the
suppression of leukocyte migration can represent one
of the pharmacological effects of NSAID after the
topic application in clinical use.
It is known that other anti-inflammatory drugs such
as dexamethasone suppress leukocyte migration [26].
It binds to its intracellular receptor and inhibits gene
expression by binding to negative regulatory promoter
regions or through protein/protein interactions [26].
The effect of NSAID corresponds well with effect of
dexamethasone. As shown in the present study, keto-
profen can block SDF-1 and IL-8-mediated leukocyte
migration. In accordance with our results, previous
studies demonstrated that dexamethasone augmented
intracellular chemokine signaling and inhibited SDF-1-
induced chemotaxis of resting T cells [27]. Further-
more, dexamethasone also suppressed IL-8-induced
chemotaxis of PMN through inhibition of endogenous
chemokine production [28]. It can be proposed that
inhibition of endogenous chemokine production by
ketoprofen or other NSAID can also participate in the
inhibition of leukocyte migration.
Conclusions
In summary, our results demonstrate that ketoprofen,
diclofenac and SC-560 have a direct suppressive effect
on haptotaxis and haptokinesis of polymorphonuclear
leukocytes and lymphocytes. This effect is dose-depen-
dent and partially reversible after removal of inhibiting
agent. This process is probably induced by COX-depen-
dent and COX-independent mechanisms whereas com-
plete blockade, but not the partial inhibition of
migration is accompanied by changes of Ca
2+signaling.
These results indicate a possible discrete mechanism of
NSAID action which may be identified in further experi-
ments. The findings of the present study may have an
important clinical implications since the blockade of
leukocyte migration can also be expected after local
application of NSAID in humans.
Additional material
Additional file 1: Time-lapse intravital microscopy of leukocyte
extravasation in mouse cutaneous tissue (auricle). Cutaneous
inflammation was induced by injection of IL-8. Neutrophils express EGFP
and appear in green. Blood vessels are labelled using intravenous
injection of TRITC-labelled albumin. Real-time recording of 30 min was
compressed to time-lapse sequence of 7 sec. control experiment; IL-8
induces an immediate extravasation and migration of leukocytes from
the venule.
Additional file 2: Time-lapse intravital microscopy of leukocyte
extravasation in mouse cutaneous tissue (auricle). Cutaneous
inflammation was induced by injection of IL-8. Neutrophils express EGFP
and appear in green. Blood vessels are labelled using intravenous
injection of TRITC-labelled albumin. Real-time recording of 30 min was
compressed to time-lapse sequence of 7 sec. Application of ketoprofen
gel prior injection of IL-8 blocks intravascular leukocyte adhesion and
extravasation.
Paskauskas et al. BMC Immunology 2011, 12:64
http://www.biomedcentral.com/1471-2172/12/64
Page 8 of 9Acknowledgements
We thank Dr. T. Graf for providing of lysEGFP-ki mice. We thank C. Bernardi
for an excellent technical assistance. We thank Dr. W. Gross for the help in
“Histo” software.
Author details
1Department of Surgery, University of Heidelberg, Heidelberg, Germany.
2Institute of Physiology, University of Heidelberg, Heidelberg, Germany.
3University of Health Sciences, Kaunas, Lithuania.
Authors’ contributions
SP: most experiments in vitro, manuscript preparation; AP and VK: design
and data analysis of leukocyte migration experiments in vitro; RN: design,
control and data aquisition of Ca
2+ measurement, JS: data analysis,
preparation of the manuscript; ER: idea and concept, study design,
haptotaxis experiments, intravital microscopy, manuscript preparation. All
authors read and approved the final manuscript.
Received: 28 July 2011 Accepted: 12 November 2011
Published: 12 November 2011
References
1. Friedl P, Weigelin B: Interstitial leukocyte migration and immune
function. Nat Immunol 2008, 9:960-969.
2. Sidiropoulos PI, Hatemi G, Song IH, Avouac J, Collantes E, Hamuryudan V,
Herold M, Kvien TK, Mielants H, Mendoza JM, et al: Evidence-based
recommendations for the management of ankylosing spondylitis:
systematic literature search of the 3E Initiative in Rheumatology
involving a broad panel of experts and practising rheumatologists.
Rheumatology (Oxford) 2008, 47:355-361.
3. Friedman ES, LaNatra N, Stiller MJ: NSAIDs in dermatologic therapy:
review and preview. J Cutan Med Surg 2002, 6:449-459.
4. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action
for aspirin-like drugs. Nat New Biol 1971, 231:232-235.
5. Morris T, Stables M, Hobbs A, de Souza P, Colville-Nash P, Warner T,
Newson J, Bellingan G, Gilroy DW: Effects of low-dose aspirin on acute
inflammatory responses in humans. J Immunol 2009, 183:2089-2096.
6. Bizzarri C, Pagliei S, Brandolini L, Mascagni P, Caselli G, Transidico P,
Sozzani S, Bertini R: Selective inhibition of interleukin-8-induced
neutrophil chemotaxis by ketoprofen isomers. Biochem Pharmacol 2001,
61:1429-1437.
7. Ryschich E, Kerkadze V, Lizdenis P, Paskauskas S, Knaebel HP, Gross W,
Gebhard MM, Buchler MW, Schmidt J: Active leukocyte crawling in
microvessels assessed by digital time-lapse intravital microscopy. J Surg
Res 2006, 135:291-296.
8. Nobiling R, Buhrle CP: A microscope fluorimeter using multiple-
wavelength excitation for ultrasensitive single-cell emission
spectrometry. J Microsc 1989, 156:149-161.
9. Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, Funahashi H,
Takeyama H, Tong Z, Guha S: CXCL8/IL-8 and CXCL12/SDF-1alpha co-
operatively promote invasiveness and angiogenesis in pancreatic
cancer. Int J Cancer 2009, 124:853-861.
10. Olson TS, Ley K: Chemokines and chemokine receptors in leukocyte
trafficking. Am J Physiol Regul Integr Comp Physiol 2002, 283:R7-28.
11. Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, Osen E, Nguyen B, Tsing S,
Bach C, Freire J, et al: Purification, characterization and selective
inhibition of human prostaglandin G/H synthase 1 and 2 expressed in
the baculovirus system. Biochim Biophys Acta 1994, 1209:130-139.
12. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL: Differential
inhibition of human prostaglandin endoperoxide H synthases-1 and -2
by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994,
271:927-934.
13. Partsch G, Schwarzer C, Eberl R: The effects of ibuprofen and diclofenac
on the chemotaxis and adenosine triphosphate level of
polymorphonuclear cells in vitro. J Rheumatol 1990, 17:583-588.
14. Queiroz-Junior CM, Pacheco CM, Maltos KL, Caliari MV, Duarte ID,
Francischi JN: Role of systemic and local administration of selective
inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of
periodontal disease in rats. J Periodontal Res 2009, 44:153-160.
15. Menezes GB, Rezende RM, Pereira-Silva PE, Klein A, Cara DC, Francischi JN:
Differential involvement of cyclooxygenase isoforms in neutrophil
migration in vivo and in vitro. Eur J Pharmacol 2008, 598:118-122.
16. Mingatto FE, Santos AC, Uyemura SA, Jordani MC, Curti C: In vitro
interaction of nonsteroidal anti-inflammatory drugs on oxidative
phosphorylation of rat kidney mitochondria: respiration and ATP
synthesis. Arch Biochem Biophys 1996, 334:303-308.
17. Legen I, Kristl A: Ketoprofen-induced intestinal permeability changes
studied in side-by-side diffusion cells. J Pharm Pharmacol 2002,
54:1419-1422.
18. Mandeville JT, Ghosh RN, Maxfield FR: Intracellular calcium levels correlate
with speed and persistent forward motion in migrating neutrophils.
Biophys J 1995, 68:1207-1217.
19. Eddy RJ, Pierini LM, Matsumura F, Maxfield FR: Ca2+-dependent myosin II
activation is required for uropod retraction during neutrophil migration.
J Cell Sci 2000, 113(Pt 7):1287-1298.
20. Wilson AK, Pollenz RS, Chisholm RL, de LP: The role of myosin I and II in
cell motility. Cancer Metastasis Rev 1992, 11:79-91.
21. Lim YJ, Lee JS, Ku YS, Hahm KB: Rescue strategies against non-steroidal
anti-inflammatory drug-induced gastroduodenal damage. J Gastroenterol
Hepatol 2009, 24:1169-1178.
22. Petersen B, Rovati S: Diclofenac epolamine (Flector) patch: evidence for
topical activity. Clin Drug Investig 2009, 29:1-9.
23. Singh P, Roberts MS: Skin permeability and local tissue concentrations of
nonsteroidal anti-inflammatory drugs after topical application. J
Pharmacol Exp Ther 1994, 268:144-151.
24. Shinkai N, Korenaga K, Okumura Y, Mizu H, Yamauchi H: Microdialysis
assessment of percutaneous penetration of ketoprofen after transdermal
administration to hairless rats and domestic pigs. Eur J Pharm Biopharm
2011, 78:415-421.
25. Tettey-Amlalo RN, Kanfer I, Skinner MF, Benfeldt E, Verbeeck RK: Application
of dermal microdialysis for the evaluation of bioequivalence of a
ketoprofen topical gel. Eur J Pharm Sci 2009, 36:219-225.
26. Ashwell JD, Lu FW, Vacchio MS: Glucocorticoids in T cell development
and function*. Annu Rev Immunol 2000, 18:309-345.
27. Ghosh MC, Baatar D, Collins G, Carter A, Indig F, Biragyn A, Taub DD:
Dexamethasone augments CXCR4-mediated signaling in resting human
T cells via the activation of the Src kinase Lck. Blood 2009, 113:575-584.
28. Zentay Z, Sharaf M, Qadir M, Drafta D, Davidson D: Mechanism for
dexamethasone inhibition of neutrophil migration upon exposure to
lipopolysaccharide in vitro: role of neutrophil interleukin-8 release.
Pediatr Res 1999, 46:406-410.
doi:10.1186/1471-2172-12-64
Cite this article as: Paskauskas et al.: Blockade of leukocyte haptokinesis
and haptotaxis by ketoprofen, diclofenac and SC-560. BMC Immunology
2011 12:64.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Paskauskas et al. BMC Immunology 2011, 12:64
http://www.biomedcentral.com/1471-2172/12/64
Page 9 of 9